Endocrinology

 
At Onorach we understand the clinical development challenges in endocrinology and can work with you to ensure your plan is strategic, efficient and effective in these areas:
  • Diabetes
  • Obesity
  • Calcium disorders (Osteoporosis)
  • Growth hormone disorders (including acromegaly)
  • Pituitary hormone disorders (including hyperprolactinemia & hyperthyroidism)
 
Onorach keep abreast of Regulatory guidance (e.g. emphasis on assessing cardiovascular risk for diabetes patients in the FDA’s focus on diabetes drug development) which has altered the clinical development landscape for anti-diabetic therapies. Onorach have strategies in place to deal with the implications of extensions to trial length, increasing costs of development and complexity of data requirements.
 
It is critical, now more than ever, to have a partner who understands the implications throughout the product lifecycle to:
  • Ensure trial development meets global regulations
  • Track cardiovascular events
  • Assess long term risk
  • Improve market access
 
Contact us for more information...

Client Testimonial

We have had nothing but an excellent experience with Onorach. We are impressed with their flexibility and proactive approach. The attitude demonstrated by the team was nothing short of 100% professional in every way and they were always prepared to go the extra mile.
A UK Client

 

Join Our MAILING LIST